Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by fullburley on Friday June 23, 2023 @12:28AM
(#36442784)
It is very expensive. We will likely have $2M USD in insurance claims for medical this year, and our son is currently aged out of the approved label. At a gross cost of $3.2M for this treatment, its expensive but definitely cost effective relatively speaking.
[ Parent
| on HN ]
Re:FDA Approves First Gene Therapy Treatment of Duchenne Mus...
by arthur2e5 on Friday June 23, 2023 @04:35AM
(#36444287)
Considering this new treatment is just a single dose[^1] that hopefully lasts for quite a while[^2], it might actually cost a lot less in the long run.
[^1] see FDA press release and monograph. addditional doses won't do much because by then the immune system has learned to attack the AAV vector -- a different vector strain would be needed and that would be a new drug to be approved
[^2] no idea what the turnover rate is. and honestly, the FDA isn't even sure it helps with anything, hence conditional.